Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
J Eur Acad Dermatol Venereol ; 31(11): 1884-1889, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28252815

RESUMO

BACKGROUND: Livedoid vasculopathy and calciphylaxis are rare skin disorders. Large cohorts of patients have been missing so far for detailed analysis. PATIENTS AND METHODS: Data from diagnosis-related groups (DRGs) of hospitalized cases of livedoid vasculopathy (ntotal = 1357) and calciphylaxis (ntotal = 699) were analysed for the years 2008-2013 concerning sex, age and frequency of diagnosis. To avoid deviations to non-relevant secondary diagnosis and due to changes in ICD-10 indices, we selected the two most recent available years 2013 and 2014 for evaluation of the accompanying diagnoses for both, livedoid vasculopathy (n = 519) and calciphylaxis (n = 324). Those were additionally evaluated as possible comorbidity. RESULTS: The male-female ratio for livedoid vasculopathy was 2.1:1. Patients older than 45 years comprehended 74.7% of all patients with peaks between the ages of 45-50 and 70-75. Livedoid vasculopathy patients suffered from cardiovascular and renal diseases. Coding of coagulation disorders was found rarely in our analysis. For calciphylaxis, we calculated a male-female ratio of 1.7:1. Most of the patients were at an age between 65 and 80 years. Diagnosis at an age under 35 years was rare. In general, most calciphylaxis patients showed end-stage renal disease with need of dialysis and presented with the resulting complications. CONCLUSIONS: Our data analysis shows relevant comorbidity and cofactors of these rare diseases like livedoid vasculopathy and calciphylaxis in Germany by a large number of cases.


Assuntos
Calciofilaxia/diagnóstico , Dermatopatias/diagnóstico , Doenças Vasculares/diagnóstico , Idoso , Feminino , Alemanha , Humanos , Masculino , Pessoa de Meia-Idade
2.
Hautarzt ; 66(10): 720-2, 2015 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-26311032

RESUMO

Cutaneous polyarteritis nodosa, a special form of polyarteritis nodosa (PAN) without systemic involvement, is classified as one of the ANCA-negative vasculitides of small and medium-sized vessels. It is a very rare disease with unknown etiology and occurs more commonly in women over the age of 40. Typical skin lesions are subcutaneous nodules, livedo racemosa, and ulcerations. We report the case of a 46-year-old woman presenting to our outpatient department who reported having very painful ulcerations of the lower legs with unknown origin for 6 months.


Assuntos
Úlcera da Perna/diagnóstico , Úlcera da Perna/etiologia , Poliarterite Nodosa/complicações , Poliarterite Nodosa/diagnóstico , Anti-Inflamatórios não Esteroides/administração & dosagem , Doença Crônica , Diagnóstico Diferencial , Feminino , Humanos , Úlcera da Perna/tratamento farmacológico , Pessoa de Meia-Idade , Ácido Micofenólico/administração & dosagem , Ácido Micofenólico/análogos & derivados , Poliarterite Nodosa/tratamento farmacológico , Resultado do Tratamento
3.
Hautarzt ; 66(10): 718-20, 2015 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-26335858

RESUMO

Juvenile systemic lupus erythematosus (JSLE) is a rare multisystem autoimmune disease with broad heterogeneity of clinical manifestations. Diagnosing JSLE is often very challenging. This life-threatening, unpredictable, and relapsing disease, which may affect various organ systems, requires interdisciplinary, lifelong care. Here, we report the case of a 13-year-old patient with JSLE suffering from recurrent arthralgia, lupus panniculitis, and rashes that were successfully treated with hydroxychloroquine and prednisolone.


Assuntos
Hidroxicloroquina/administração & dosagem , Lúpus Eritematoso Sistêmico/diagnóstico , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Paniculite de Lúpus Eritematoso/diagnóstico , Paniculite de Lúpus Eritematoso/tratamento farmacológico , Prednisolona/administração & dosagem , Adolescente , Anti-Inflamatórios/administração & dosagem , Diagnóstico Diferencial , Quimioterapia Combinada/métodos , Humanos , Lúpus Eritematoso Sistêmico/complicações , Masculino , Paniculite de Lúpus Eritematoso/etiologia , Recidiva , Resultado do Tratamento
4.
Hautarzt ; 64(9): 685-94, 2013 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-24022632

RESUMO

BACKGROUND: Phlebologic diseases have become extremely common and have major socio-economic impact. However, the percentage of dermatologists working in phlebology appears to be decreasing according to the data of the German Society of Phlebology (DGP). METHODS: To investigate the reasons for this development, we--on behalf of the DGP--sent a questionnaire to 120 German Departments of Dermatology in autumn 2012. RESULTS: In 76 returned questionnaires, the number of physicians with additional fellowship training in phlebology averaged 1.5; the average number of those who fulfill the criteria for training fellows in phlebology was 0.9. In 71.1 % of the departments there was a phlebologist. A special phlebologic outpatient clinic existed in 73.7 % of the departments. Sonography with Doppler (89.5 %) and duplex (86.8 %) was used as the most frequent diagnostic tool. For therapy, compression (94.7 %), sclerotherapy (liquid 78.9 %, foam 63.2 %, catheter 18.4 %), endoluminal thermic procedures (radio wave 28.9 %, laser 17.1 %) and surgery (especially crossectomy and stripping 67.1 %, phlebectomy of tributaries 75 %) were used. The average number of treatments was very heterogenous in the different departments. CONCLUSIONS: Phlebology definitely plays an important role in dermatology. Most departments fulfill the formal criteria for the license to conduct advanced training in phlebology. A wide spectrum of phlebological diagnostic and therapeutic procedures is available.


Assuntos
Dermatologia/estatística & dados numéricos , Departamentos Hospitalares/estatística & dados numéricos , Padrões de Prática Médica/estatística & dados numéricos , Dermatopatias Vasculares/diagnóstico , Dermatopatias Vasculares/terapia , Insuficiência Venosa/diagnóstico , Insuficiência Venosa/terapia , Alemanha/epidemiologia , Humanos , Competência Profissional/estatística & dados numéricos , Dermatopatias Vasculares/epidemiologia , Inquéritos e Questionários , Insuficiência Venosa/epidemiologia
5.
Hautarzt ; 63(4): 278-82, 2012 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-22430612

RESUMO

A 35-year-old man presented with swelling, indurations and nodules on the thumb, wrist and fingers of the right hand. History revealed that the findings were slowly progressive and had been present for at least eight years. Histopathologic analysis of a nodule showed a diffuse infiltrate with atypical spindle-shaped cells and expression of cytokeratin, epithelial membrane antigen (EMA) and CD34; the diagnosis of epithelioid sarcoma (ES) was made. Because of diffuse extension of the tumor, forearm amputation was performed along with axillary dissection and local radiotherapy because of axillary lymph node metastases. ES is a rare subtype of soft tissue sarcoma with a harmless appearance and indolent course over years. ES represents a diagnostic challenge, with consequent delay in diagnosis and adequate treatment. The most important measure in the treatment of ES is early surgical excision with adjuvant radiotherapy if local metastases are present.


Assuntos
Amputação Cirúrgica , Mãos/patologia , Radioterapia Adjuvante , Sarcoma/patologia , Sarcoma/cirurgia , Adulto , Humanos , Masculino , Resultado do Tratamento
6.
Hautarzt ; 63(10): 766-7, 2012 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-23008008

RESUMO

A 71-year-old man presented with disfiguring skin changes of the nose and cheek. The patient had undergone a surgery of a malignant melanoma of the right paranasal sinus and then 5 months later received radiation therapy with 60 Gy total dose to the endonasal area. Physical examination revealed elastosis, open and closed comedones, and cysts in the field of radiation exposure. Taking in account the exclusive affection of the irradiated skin, we diagnosed a radiation-induced Favre-Racouchot disease. We recommended topical treatment with vitamin A derivatives in combination with physical comedo extraction.


Assuntos
Dermatoses Faciais/diagnóstico , Dermatoses Faciais/etiologia , Radiodermite/diagnóstico , Radiodermite/etiologia , Radioterapia Conformacional/efeitos adversos , Idoso , Dermatoses Faciais/terapia , Humanos , Masculino , Radiodermite/terapia , Resultado do Tratamento
7.
Eur J Med Res ; 16(11): 491-4, 2011 Nov 10.
Artigo em Inglês | MEDLINE | ID: mdl-22027642

RESUMO

Pyoderma gangrenosum is a non-infectious neutro?philic skin disease commonly associated with underlying systemic diseases. Histopathological and laboratory diagnostics are unspecific in the majority of the cases and the diagnosis is made in accordance with the clinical picture. Here, we report the case of a 69-year old man with progredient pyoderma gangrenosum-like ulcerations under treatment with sunitinib due to hepatocellular carcinoma. A conventional ulcer therapy did not lead to a regression of the lesions. Solely cessation of sunitinib therapy resulted in an improvement of the ulcerations. Sunitinib is a multikinase inhibitor that targets the PDGF-α- and ?ß-, VEGF-1-3-, KIT-, FLT3-, CSF-1- and RET-receptor, thereby impairing tumour proliferation, pathological angiogenesis and metastasation. Here, we demonstrate that pyoderma gangrenosum-like ulcers may represent a serious side effect of sunitinib-based anti-cancer treatment.


Assuntos
Antineoplásicos/efeitos adversos , Indóis/efeitos adversos , Pioderma Gangrenoso/induzido quimicamente , Pioderma Gangrenoso/complicações , Pirróis/efeitos adversos , Úlcera/induzido quimicamente , Úlcera/complicações , Idoso , Eritema/induzido quimicamente , Eritema/complicações , Humanos , Hiperpigmentação/induzido quimicamente , Hiperpigmentação/complicações , Hipopigmentação/induzido quimicamente , Hipopigmentação/complicações , Masculino , Tratamento de Ferimentos com Pressão Negativa , Pioderma Gangrenoso/terapia , Sunitinibe , Úlcera/terapia
8.
Eur J Med Res ; 16(10): 437-44, 2011 Oct 10.
Artigo em Inglês | MEDLINE | ID: mdl-22024422

RESUMO

Patients with ESCC (squamous cell carcinoma of the esophagus) are most commonly diagnosed with locally advanced tumor stages. Early metastatic disease and late diagnosis are common reasons responsible for this tumor's poor clinical outcome. The prognosis of esophageal cancer is very poor because patients usually do not have symptoms in early disease stages. Squamous cell carcinoma of the esophagus frequently complicates patients with multiple co-morbidities and these patients often require interdisciplinary diagnosis and treatment procedures. At present time, neoadjuvant radiation therapy and chemotherapy followed by surgery are regarded as the international standard of care. Meta-analyses have confirmed that this approach provides the patient with better local tumor control and an increased overall survival rate. It is recommended that patients with positive tumor response to neoadjuvant therapy and who are poor surgical candidates should consider definitive radiochemotherapy without surgery as a treatment option. In future, EGFR antibodies may also be administered to patients during therapy to improve the current treatment effectiveness. Positron-emission tomography proves to be an early response-imaging tool used to evaluate the effect of the neoadjuvant therapy and could be used as a predictive factor for the survival rate in ESCC. The percentage proportions of residual tumor cells in the histopathological analyses represent a gold standard for evaluating the response rate to radiochemotherapy. In the future, early response evaluation and molecular biological tests could be important diagnostic tools in influencing the treatment decisions of ESCC patients.


Assuntos
Carcinoma de Células Escamosas/terapia , Neoplasias Esofágicas/terapia , Esofagectomia , Terapia Neoadjuvante , Carcinoma de Células Escamosas/patologia , Quimioterapia Adjuvante , Terapia Combinada , Neoplasias Esofágicas/patologia , Humanos , Metanálise como Assunto , Estadiamento de Neoplasias , Radioterapia Adjuvante , Padrão de Cuidado , Taxa de Sobrevida , Resultado do Tratamento
9.
Eur J Med Res ; 16(10): 451-6, 2011 Oct 10.
Artigo em Inglês | MEDLINE | ID: mdl-22024424

RESUMO

OBJECTIVE: Insulin-like growth factor (IGF)-1, -2 and Insulin like growth factor binding proteins (IGFBP) are involved in the proliferation and differentiation of cells. It has never been evaluated, if the IGF-system can serve as a tumor marker in neoplasms. METHODS: In our prospective study 163 patients with colorectal cancer (22), prostate cancer (21), head and neck tumors (17), lymphomas (20), lung cancer (34) and other entities (49) were analysed for their IGF and IGFBP serum levels at the beginning and the end of radiotherapy and compared to 13 healthy people. Subgroups of patients with local tumor disease versus metastatic disease, primary and recurrent therapy and curative versus palliative therapy were compared. RESULTS: The serum levels of IGF-2 were significantly elevated in patients with prostate and colorectal cancer. However, sensitivity and specificity were only 70%. IGFBP-2 serum levels were elevated in patients with head and neck tumors. Again sensitivity and specificity were only 73%. A difference between local disease and metastatic disease could not be found. A difference between IGF serum levels before and after radiotherapy could not be detected. CONCLUSION: The IGF-system cannot serve as a new tumor marker. The detected differences are very small, sensitivity and specificity are too low. IGF measurement is not useful for the evaluation of the success of radiotherapy in malignancies.


Assuntos
Biomarcadores Tumorais/sangue , Proteína 2 de Ligação a Fator de Crescimento Semelhante à Insulina/sangue , Proteína 3 de Ligação a Fator de Crescimento Semelhante à Insulina/sangue , Fator de Crescimento Insulin-Like II/metabolismo , Fator de Crescimento Insulin-Like I/metabolismo , Neoplasias/sangue , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Casos e Controles , Estudos de Coortes , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias/diagnóstico , Prognóstico , Estudos Prospectivos , Sensibilidade e Especificidade , Adulto Jovem
10.
Hautarzt ; 62(7): 509-15, 2011 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-21681545

RESUMO

Calciphylaxis is a rare disease associated with thrombotic cutaneous ischemia and necrosis. Lesions are usually located on the lower extremities, buttocks and the abdomen. Calciphylaxis is recognized by medial calcification, inflammation and subintimal fibrosis of cutaneous arterioles. Calcification, thrombus formation and occlusion occur sequential before tissue necrosis. The disease is usually observed in patients with end-stage renal disease and hyperparathyroidism. In end-stage renal disease, an elevated parathyroid hormone level, hypercalcemia and hyperphosphatemia direct to vascular mineralization. Calciphylaxis affects about 4% of hemodialysis patients. The clinical syndrome is characterized by a high mortality rate. The most important measure is an active multidisciplinary management approach, with intention to wound care and prevention of sepsis.


Assuntos
Calciofilaxia/diagnóstico , Úlcera Cutânea/diagnóstico , Calciofilaxia/fisiopatologia , Calciofilaxia/terapia , Distúrbio Mineral e Ósseo na Doença Renal Crônica/complicações , Distúrbio Mineral e Ósseo na Doença Renal Crônica/fisiopatologia , Distúrbio Mineral e Ósseo na Doença Renal Crônica/terapia , Terapia Combinada , Comportamento Cooperativo , Humanos , Comunicação Interdisciplinar , Isquemia/complicações , Isquemia/fisiopatologia , Isquemia/terapia , Falência Renal Crônica/complicações , Falência Renal Crônica/fisiopatologia , Falência Renal Crônica/terapia , Necrose , Equipe de Assistência ao Paciente , Diálise Renal , Pele/irrigação sanguínea , Pele/patologia , Úlcera Cutânea/fisiopatologia , Úlcera Cutânea/terapia , Trombose/complicações , Trombose/fisiopatologia , Trombose/terapia , Cicatrização/fisiologia
11.
Hautarzt ; 61(10): 831-3, 2010 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-20865235

RESUMO

A female infant, aged two weeks, presented with linear erythematous crusted papules, plaques and blisters on the right leg which had occurred two days after birth. Histological examination revealed typical features of incontinentia pigmenti in the inflammatory stage. Incontinentia pigmenti is a rare X-linked dominant genodermatosis caused by mutations in the NEMO gene located at Xq28 affecting the skin, different organ systems, the central nervous system, eyes, teeth and skeleton with variable expression. We summarize important clinical and diagnostic aspects of incontinentia pigmenti as well as its genetic and molecular basis.


Assuntos
Incontinência Pigmentar/diagnóstico , Cromossomos Humanos X/genética , Feminino , Genes Dominantes/genética , Aconselhamento Genético , Humanos , Quinase I-kappa B/genética , Incontinência Pigmentar/genética , Incontinência Pigmentar/patologia , Recém-Nascido , Mutação , Aberrações dos Cromossomos Sexuais , Pele/patologia
12.
Hautarzt ; 61(4): 286-90, 2010 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-20300721

RESUMO

Langerhans cell histiocytosis is the general term for all clinical entities characterized by a proliferation of dendritic cells that are phenotypically identical to the Langerhans cells of the skin. As dendritic cells are present in nearly every tissue of the body, Langerhans cell histiocytosis shows a broad spectrum of clinical manifestations, mostly in the bone (approximately 80%) and skin (approximately 60%). Langerhans cell histiocytosis is basically a disease of the childhood and early youth, but can rarely occur in the elderly. Here, we report on a 70-year-old man presenting with a single facial lesion of Langerhans cell histiocytosis and summarize the most important clinical aspects as well as current therapeutic concepts.


Assuntos
Dermatoses Faciais/diagnóstico , Dermatoses Faciais/terapia , Histiocitose de Células de Langerhans/diagnóstico , Histiocitose de Células de Langerhans/terapia , Idoso , Humanos , Masculino
13.
G Ital Dermatol Venereol ; 145(3): 345-59, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20461043

RESUMO

Cutaneous T-cell lymphoma represents a broad spectrum of disorders with various manifestations, clinical courses, and therapeutic considerations. Mycosis fungoides is the most common form of cutaneous T-cell lymphoma, the skin being affected by erythematous patches, plaques, or tumors. The related Sézary syndrome is a more aggressive form of cutaneous T-cell lymphoma with cutaneous and leukemic manifestations. Recent advances in the understanding of the molecular and biologic behavior of T cells in these disorders have facilitated the development of novel treatments, using biologic agents, phototherapeutic methods, and irradiation techniques. Nevertheless, there remains a continued need to develop new therapeutic options, particularly for patients with advanced-stage and treatment-refractory disease. At present, hematopoietic stem-cell transplantation has the best chance for expanding the therapeutic armamentarium of cutaneous T-cell lymphoma. In advanced-stage mycosis fungoides and the Sézary syndrome, stem cell transplantation may result in sustained remissions and improvement of progression-free survival. However, physicians have to be aware of severe clinical problems like graft-versus-host disease as well as increased risk of infection and secondary cancers. In this review, we focus on the role of hematopoietic stem cell transplantation for the therapy of mycosis fungoides and the Sézary syndrome.


Assuntos
Transplante de Células-Tronco Hematopoéticas , Linfoma Cutâneo de Células T/cirurgia , Neoplasias Cutâneas/cirurgia , Progressão da Doença , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Humanos , Linfoma Cutâneo de Células T/classificação , Linfoma Cutâneo de Células T/terapia , Neoplasias Cutâneas/classificação , Neoplasias Cutâneas/terapia
14.
New Microbes New Infect ; 34: 100640, 2020 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32025309

RESUMO

Different species of adenoviruses (AdVs) infect humans and animals and are known for their role as pathogens, especially in humans, with animals, primarily rodents, often serving as model systems. However, although we know over 100 types of human AdVs, we know comparatively little about the diversity of animal AdVs. Due to the fact that rodents are the most diverse family of mammals and a standard model system for human disease, we set out to sample African rodents native to the Democratic Republic of the Congo and test them for AdV DNA using a semi-nested consensus PCR. A total of 775 animals were tested, and viral DNA was detected in four of them. The AdV DNA found belongs to three different AdVs, all being closely related to murine adenovirus 2 (MAdV-2). Considering the genetic differences of the amplicon were 9%, 11% and 19% from MAdV-2 and at least 10% from each other, they seem to belong to up to three different novel types within the Murine mastadenovirus B species. This evidence of genetic diversity highlights the opportunities to isolate and study additional AdVs that infect rodents as models for AdV biology and pathology.

15.
Hautarzt ; 60(10): 783-7, 2009 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-19756436

RESUMO

A 68-year-old women with polycythemia vera was treated with hydroxyurea for 8 years and developed painful ulcers on her lower legs, multiple hypertrophic actinic keratoses and a squamous cell carcinoma. After discontinuing hydroxyurea therapy the leg ulcers resolved within 8 weeks. The hypertrophic actinic keratoses and squamous cell carcinoma were treated with cryotherapy and excision, respectively. Hydroxyurea induces a variety of cutaneous side effects such as painful leg ulcers and squamous cell carcinomas. Given the wide variety of adverse cutaneous side effects associated with long-term hydroxyurea therapy, the first step in management is to insure that physicians and patients are aware of the specific risks of this treatment. Patients under hydroxyurea therapy should be monitored closely by dermatologists to early detect and treat the cutaneous side effects.


Assuntos
Carcinoma de Células Escamosas/induzido quimicamente , Toxidermias/diagnóstico , Hidroxiureia/efeitos adversos , Úlcera da Perna/induzido quimicamente , Úlcera da Perna/diagnóstico , Neoplasias Cutâneas/induzido quimicamente , Idoso , Antidrepanocíticos/efeitos adversos , Antidrepanocíticos/uso terapêutico , Carcinoma de Células Escamosas/diagnóstico , Toxidermias/etiologia , Feminino , Humanos , Hidroxiureia/uso terapêutico , Policitemia Vera/complicações , Policitemia Vera/tratamento farmacológico , Neoplasias Cutâneas/diagnóstico
16.
Hautarzt ; 60(4): 275-8, 2009 Apr.
Artigo em Alemão | MEDLINE | ID: mdl-19296059

RESUMO

Merkel cell carcinoma (cutaneous neuroendocrine carcinoma) is a rare, highly malignant, neuroendocrine tumor of the skin with predominance in older patients. The tumor is most often located in the sun-exposed skin of the head, the neck and -as in our patient - the extremities. Notably, the tumor bears a high risk of an early regional lymph node as well as distant metastases. Clinically, only a presumptive diagnosis of Merkel cell carcinoma can be established. The definite diagnosis is made by histological and immunohistological methods. Surgical excision with a safety margin should be combined with sentinel lymph node biopsy. In advanced tumor stages (lymph node or visceral metastasis), a remission can be achieved by different chemotherapy schedules in combination with radiation. Recently, a previously unknown polyomavirus, named Merkel cell polyomavirus (MCV or MCPyV), has been identified in 80% of Merkel cell carcinomas. In the near future, these novel findings could be utilized to distinguish Merkel cell carcinoma from small round cell cancers and could lead to the development of new therapeutic options.


Assuntos
Carcinoma de Célula de Merkel/terapia , Carcinoma de Célula de Merkel/virologia , Polyomavirus/patogenicidade , Neoplasias Cutâneas/terapia , Neoplasias Cutâneas/virologia , Carcinoma de Célula de Merkel/diagnóstico , Humanos , Neoplasias Cutâneas/diagnóstico
17.
Hautarzt ; 59(10): 779-82, 2008 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-18773178

RESUMO

Mycosis fungoides is the most common type of cutaneous T-cell lymphoma and characterized by a chronic progressive course spanning decades. The choice of treatment options should be tailored to the stage depending on the extent and aggressiveness of the disease and taking the individual situation of the patient into consideration. Long-term complete remissions can only be achieved in the early phase of the disease, while there is no therapy that results in a cure or long-term remission in advanced stages. In young patients with a treatment-refractory course of mycosis fungoides, allogeneic stem cell transplantation represents an important alternative option to manage the disease since complete clinical remission can be obtained even in advanced stages.


Assuntos
Micose Fungoide/patologia , Micose Fungoide/cirurgia , Transplante de Células-Tronco/métodos , Humanos , Masculino , Pessoa de Meia-Idade , Falha de Tratamento , Resultado do Tratamento
18.
Int J STD AIDS ; 26(3): 187-95, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24828556

RESUMO

Despite recent declines in HIV incidence, sub-Saharan Africa remains the most heavily affected region in the global HIV/AIDS epidemic. Estimates of HIV prevalence in African military personnel are scarce and inconsistent. We conducted a serosurvey between June and September 2007 among 4043 Armed Forces personnel of the Democratic Republic of Congo (FARDC) stationed in Kinshasa, Democratic Republic of Congo (DRC) to determine the prevalence of HIV and syphilis infections and describe associated risk behaviours. Participants provided blood for HIV and syphilis testing and responded to a demographic and risk factor questionnaire. The prevalence of HIV was 3.8% and the prevalence of syphilis was 11.9%. Women were more likely than men to be HIV positive, (7.5% vs. 3.6% respectively, aOR: 1.66, 95% C.I: 1.21-2.28, p < 0.05). Factors significantly associated with HIV infection included gender and self-reported genital ulcers in the 12 months before date of enrollment. The prevalence of HIV in the military appears to be higher than the general population in DRC (3.8% vs. 1.3%, respectively), with women at increased risk of infection.


Assuntos
Infecções por HIV/epidemiologia , Militares , Sífilis/epidemiologia , Adulto , Estudos Transversais , República Democrática do Congo/epidemiologia , Feminino , Infecções por HIV/sangue , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Prevalência , Fatores de Risco , Fatores Socioeconômicos , Inquéritos e Questionários , Sífilis/sangue
19.
Int J Epidemiol ; 8(1): 41-7, 1979 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-489223

RESUMO

A cohort analysis of lung cancer mortality in the Netherlands from 1936--1974 is presented. Apart from small corrections, age-specific lung cancer mortality rates can be expressed as the product of a cohort (generation) factor and an age factor. The cohort factors increase until the 1930 birth cohort, after which there is a rapid decline. The age-risk factors increase smoothy with age. Age-specific incidence curves of past and future years will follow the curve of the age-risk factors provided that the cohort-risk factors are unchanging. The method can be applied to other chronic diseases.


Assuntos
Neoplasias Pulmonares/mortalidade , Adulto , Fatores Etários , Idoso , Humanos , Neoplasias Pulmonares/epidemiologia , Masculino , Pessoa de Meia-Idade , Países Baixos
20.
Dtsch Med Wochenschr ; 136(43): 2205-11, 2011 Oct.
Artigo em Alemão | MEDLINE | ID: mdl-22009175

RESUMO

Locally advanced gastric cancers are characterized by poor prognosis. Clinical outcome can be improved if surgery becomes part of a multimodal treatment approach. The purpose of neoadjuvant treatment includes downsizing of the primary tumor, improvement of the T- and N- categories, and early therapy of micrometastasis. Several controlled clinical trials showed that neoadjuvant chemotherapy as well as neoadjuvant combined radio-chemotherapy, especially for tumors of the gastroesophageal junction, can improve the rate of primary R0 resections, relapse-free survival, and overall survival. While patients with locally advanced tumors clearly benefit from this strategy, the approach is still controversial in patients with early stage disease. Nonresponders do not benefit from neoadjuvant therapy. Therefore, response evaluation and response prediction are of great importance. After successful neoadjuvant chemotherapy, patients should undergo gastrectomy with D(2)-lymphadenectomy because of a high probability of lymph node metastasis. This article summarizes current developments in this field.


Assuntos
Micrometástase de Neoplasia/terapia , Neoplasias Gástricas/terapia , Quimiorradioterapia Adjuvante , Quimioterapia Adjuvante , Terapia Combinada , Humanos , Excisão de Linfonodo , Terapia Neoadjuvante , Micrometástase de Neoplasia/prevenção & controle , Estadiamento de Neoplasias , Prognóstico , Radioterapia Adjuvante , Neoplasias Gástricas/patologia , Neoplasias Gástricas/cirurgia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa